Comment: Botulinum toxin and urogenital conditions
Paul Woolley
pp 3-3
In the summer of 2004, the BBC
reported on its website, under the heading ‘Botox could treat sexual disorder’, the results of a little-known study from Iran that had been presented earlier at a European fertility conference in Berlin. Researchers at Tehran University of Medical Sciences had successfully used botulinum toxin to treat
vaginismus in 23 women. At the same time, The Daily Telegraph published an online article on the same subject, reporting on the success rate after just the first injection.
|
HIV-positive women and contraception: part 2
Laura Waters, Joel Myers and Leena Sathia
pp 4-7
Hormonal contraception is susceptible to drug–drug interactions when prescribed concomitantly with antiretrovirals, and only barrier methods offer protection against sexually transmitted infections (STIs) – so patients must be
counselled accordingly. The second part of this article (part 1 was published in issue 30.4) discusses hormonal contraception, intrauterine
devices and sterilisation for HIV-positive women.
|
Premature ejaculation: new treatments and definitions
Sailaja Pisipati, Stephen J Bromage and Ian Pearce
pp 8-10
Premature ejaculation (PE) is the most common form of sexual dysfunction reported by men. It has recently been the subject of much debate and research, which has led to innovative treatment strategies and changes in its definition. Despite a prevalence ranging from 21% to
31%,2,5,6 it is the disorder for which men are the least likely to seek professional help.
|
Optimising quality of life after breast cancer
Margaret Rees
pp 12-14
The lifetime risk of being diagnosed with breast cancer is one in nine, and there are 44,335 new cases diagnosed each year in the UK. Breast
cancer risk is strongly related to age, with more
than 80% of cases occurring in women over 50 years old. The highest incidence of breast cancer is in women aged 50–64. However, breast cancer is the most commonly diagnosed cancer in women under 35. By age 35–39, almost 1,500 women are diagnosed each year.
|
HIV: more challenges ahead for Terrence Higgins Trust
Paul Ward
pp 15-15
HIV and sexual ill health are at an all time high in the UK. HIV transmission continues to rise and too many people living with HIV are undiagnosed. Levels of sexually transmitted infections
(STIs) remain high, and there is still insufficient support for people living with HIV
to help them manage their condition.
|
Vulval dermatoses – a quick and easy guide to diagnosis
Fiona M Lewis
pp 16-18
Patients present to the vulval clinic with a range of conditions – infections, pain syndromes, neoplasia and, most commonly, inflammatory dermatoses. In some dermatoses, the vulva may be
the only site affected, whereas in many others, the vulva is involved as part of more generalised disease. A knowledge of the basic features of the common dermatoses can lead to rapid diagnosis and the correct management for these women,
who may well have delayed seeking advice because of embarrassment or fear of a sexually transmitted disease. This article gives a brief
overview of the common inflammatory dermatoses that affect the vulva.
|
Hitting the spot
David Hicks
pp 19-19
It has been an international quest led by an eminent male researcher and his female acolyte to discover a secret so powerful that it could
shake the very foundations of mankind. No, it is not the search for the Holy Grail, but the quest to detect the G spot.
|